Skip to main content
Premium Trial:

Request an Annual Quote

Cereon Genomics, Univ. of Richmond Sequence Agrobacterium Tumefaciens

SAN FRANCISCO, Dec. 13 - Researchers from Cereon Genomics and the University of Richmond described the sequence of the bacterium Agrobacterium tumefaciens strain C58 in the current issue of the journal Science.


A. tumefaciens, which is capable of naturally transferring DNA to plant cells, "is one of the most important tools for plant biotechnology," Brad Goodner, research leader of the University of Richmond sequencing team, said in a statement. "Our understanding of this bacterium and its natural ability to stably insert genes into plants has allowed the development of many of the crops enhanced through biotechnology that farmers are growing today.


"The availability of the genomic sequence can help to improve the process of producing new crop varieties through biotechnology," he added.


The DNA sequence, which includes two plasmids and two chromosomes, has been downloaded to the NationalCenter for Biotechnology Information's GenBank.


Cereon Genomics, based in Cambridge, Mass., is a subsidiary of St. Louis-based Monsanto.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.